Dr. Chotani has a career spanning over two decades as a preeminent figure in biodefense, infectious disease epidemiology, public health, and emergency management. He is an internationally recognized authority in medical countermeasure development, healthcare management, and diagnosis of human and zoonotic diseases, has received prestigious accolades such as the NATO Scientific Award for Counterterrorism, inclusion in Pakistan’s Honor List for his global COVID-19 work, and in 2022 received the Pride of Pakistan Medal of Honor from the President of Pakistan for his public health, humanitarian and charitable work.
During the COVID-19 pandemic he led the missions in 6 states to vaccinate 1.7M people, treat over 80,000 with mAb, test over 400,000 and stand up two field hospitals. He has served as a Professor at the Johns Hopkins University School of Medicine & Public Health and; Adjunct Professor, at the George Washington University. Dr. Chotani has provided key leadership to the Chemical Biological Defense Programs as the Chief Scientist at the Joint Program Executive Office (JPEO), and the Joint Science & Technology Office’s (JSTO) for applied research and development projects focused on developing FDA-compliant therapeutics, vaccines and diagnostic devices. In 1999, after finishing his fellowship in Hospital Epidemiology at the Johns Hopkins Hospital, he was selected as a DARPA postdoctoral fellow at the Johns Hopkins Applied Physics Laboratory to develop the first Early Detection of Bioterrorism System. He completed a 2-year proof-of-concept challenge in 8 months, and then led to operationalizing the concept. Ultimately, this program became operational as ESSENCE at the DoD and was adopted by the CDC in their BioSense program.
Currently, Dr. Chotani holds appointments as the Chief Medical Officer, IEM International; and Adjunct Professor of Epidemiology at the University of Nebraska Medical Center.